Alvotech (ALVO)
NASDAQ: ALVO · Real-Time Price · USD
4.690
-0.040 (-0.85%)
Jan 9, 2026, 1:33 PM EST - Market open
Alvotech Market Cap
Alvotech has a market cap or net worth of $1.47 billion as of January 9, 2026. Its market cap has decreased by -59.14% in one year.
Market Cap
1.47B
Enterprise Value
2.72B
1-Year Change
-59.14%
Ranking
Category
Stock Price
$4.69
Market Cap Chart
Since November 9, 2020, Alvotech's market cap has increased from $304.69M to $1.47B, an increase of 381.82%. That is a compound annual growth rate of 35.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 8, 2026 | 1.48B | -7.80% |
| Dec 31, 2025 | 1.61B | -59.76% |
| Dec 31, 2024 | 3.99B | 30.92% |
| Dec 29, 2023 | 3.05B | 22.59% |
| Dec 30, 2022 | 2.49B | 705.34% |
| Dec 31, 2021 | 308.75M | -5.82% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 971.66B |
| Johnson & Johnson | 495.71B |
| AbbVie | 396.12B |
| UnitedHealth Group | 314.19B |
| AstraZeneca | 295.31B |
| Merck & Co. | 275.48B |
| Novartis AG | 273.11B |
| Novo Nordisk | 256.73B |